FANDOM


This article is a working preliminary draft, NOT yet submitted for peer review. Leave your comments on the discussion page (talk page) or contact the First Author, BirenSaraiya, at their talk page or by email.

Return to Journal of South Asian Health

CAD and Platelet Dysfunction

IntroductionEdit

Treatment of Acute Coronary Syndrome (ACS) involves many of the platelet modulating drugs such as Aspirin, GPIIb/IIIa inhibitors.

Primary Prevention of Coronary Artery Disease includes Aspirin. Secondary Prevention of CAD includes Aspirin.

Though the current models for atherosclerosis does not revolve around platelet abnormalities: the question raised here is: 1. Are there any platelet speicific pathophysiology that predispose one to have ACS. 2. Are there any interventions (other than Aspirin) that are specifically related to platelets for primary/secondary prevention.

We will first review: 1. Platelet physiology 2. Atherosclerosis physiology

EpidemiologyEdit

GeneticsEdit

PathophysiologyEdit

Clinical PresentationEdit

DiagnosticsEdit

TreatmentEdit

PrognosisEdit

Associated Diseases and complicationsEdit

BibliographyEdit

Further research suggestions/DiscussionEdit

Ad blocker interference detected!


Wikia is a free-to-use site that makes money from advertising. We have a modified experience for viewers using ad blockers

Wikia is not accessible if you’ve made further modifications. Remove the custom ad blocker rule(s) and the page will load as expected.